4506
COM:SUMITOMO-PHARMA
Sumitomo Pharma Co., Ltd.
- Stock
Last Close
606.00
13/11 06:45
Market Cap
162.09B
Beta: -
Volume Today
4.13M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 34.71B - | 33.76B 2.75% | 39.56B 17.20% | 47.22B 19.36% | 53.45B 13.20% | 48.63B 9.02% | 35.92B 26.14% | 36.83B 2.54% | 40.60B 10.24% | -96.71B 338.21% | -314.97B 225.67% | |
depreciation and amortization | 26.78B - | 19.23B 28.20% | 20.27B 5.40% | 18.62B 8.13% | 12.89B 30.78% | 13.98B 8.45% | 17.36B 24.25% | 22.67B 30.57% | 38.35B 69.14% | 41.26B 7.60% | 37.77B 8.48% | |
deferred income tax | ||||||||||||
stock based compensation | ||||||||||||
change in working capital | -6.93B - | 12.99B 287.46% | 12.21B 6.02% | 6.72B 44.94% | 15.52B 130.88% | -13.82B 189.07% | -20.85B 50.85% | 66.33B 418.08% | -33.73B 150.86% | 34.88B 203.39% | -95.85B 374.81% | |
accounts receivables | -3.63B - | -16.37B 351.07% | 185M 101.13% | -6.10B 3,395.68% | 51.22B 940.05% | 23.39B 54.33% | ||||||
inventory | 4.92B - | -790M 116.06% | -3.03B 283.04% | -9.27B 206.21% | -4.38B 52.71% | -3.21B 26.81% | -14.35B 347.58% | -10.04B 30.06% | 5.36B 153.35% | 4.56B 14.86% | -11.79B 358.66% | |
accounts payables | -10.87B - | 15.24B 240.22% | -320M 102.10% | -28.67B 8,859.06% | 5.32B 118.55% | 5.64B 6.15% | ||||||
other working capital | -11.85B - | 13.78B 216.31% | 15.23B 10.55% | 15.99B 4.94% | 19.90B 24.48% | 3.88B 80.49% | -5.37B 238.17% | 76.50B 1,525.93% | -4.32B 105.65% | -26.22B 506.48% | -113.09B 331.33% | |
other non cash items | -4.61B - | -35.72B 674.52% | -22.62B 36.68% | -50.93B 125.17% | 11.56B 122.71% | -69M 100.60% | 13.70B 19,950.72% | 9.77B 28.66% | -13.98B 243.02% | 32.51B 332.61% | 189.45B 482.74% | |
net cash provided by operating activities | 49.94B - | 30.25B 39.43% | 49.41B 63.35% | 21.62B 56.24% | 93.42B 332.02% | 48.71B 47.86% | 46.13B 5.30% | 135.60B 193.97% | 31.24B 76.96% | 11.94B 61.79% | -241.89B 2,126.41% | |
investments in property plant and equipment | -21.56B - | -12.37B 42.63% | -9.74B 21.24% | -13.46B 38.18% | -12.35B 8.21% | -12.91B 4.53% | -13.35B 3.38% | -10.81B 19.06% | -13.49B 24.88% | -12.74B 5.57% | -15.73B 23.45% | |
acquisitions net | -2.83B - | -729M 74.19% | -1.26B 73.53% | -84.35B 6,567.83% | 9.42B 111.17% | 1.69B 82.03% | -205.77B 12,254.40% | 15.92B 107.74% | -3.70B 123.24% | 30.17B 915.24% | 9.04B 70.04% | |
purchases of investments | -51.60B - | -36.02B 30.18% | -297M 99.18% | -356M 19.87% | -6.23B 1,648.88% | -2.78B 55.38% | -112.49B 3,949.46% | -9.37B 91.67% | -25.91B 176.59% | -6.25B 75.88% | -4.77B 23.61% | |
sales maturities of investments | 50.00B - | 50.82B 1.64% | 24.88B 51.04% | 8.94B 64.09% | 31M 99.65% | -1.69B 5,561.29% | 1.62B 195.87% | 8.14B 401.60% | 19.47B 139.18% | 10.07B 48.29% | 34.50B 242.66% | |
other investing activites | -234M - | 21.75B 9,392.74% | 2.31B 89.39% | 29.50B 1,178.67% | -7.40B 125.08% | -19.36B 161.69% | 17.31B 189.44% | 4.98B 71.22% | 5.35B 7.37% | 31.17B 482.58% | 10B 67.92% | |
net cash used for investing activites | -26.21B - | 23.45B 189.47% | 15.89B 32.24% | -59.73B 475.96% | -16.52B 72.34% | -35.05B 112.12% | -312.68B 792.13% | 8.88B 102.84% | -18.28B 305.95% | 52.42B 386.79% | 33.04B 36.98% | |
debt repayment | -20B - | -10.35B 48.26% | -36.53B 253.01% | -22B 39.77% | -19.40B 11.82% | -12.96B 33.20% | -19.62B 51.41% | -2.96B 84.92% | -4.96B 67.57% | -20.06B 304.44% | -84B 318.74% | |
common stock issued | ||||||||||||
common stock repurchased | ||||||||||||
dividends paid | -7.15B - | -7.15B 0% | -7.15B 0% | -7.15B 0.01% | -7.94B 11.09% | -11.12B 40.01% | -13.11B 17.84% | -11.12B 15.15% | -11.13B 0.05% | -11.13B 0.01% | -2.79B 74.90% | |
other financing activites | -12M - | 1.77B 14,891.67% | 1.08B 39.38% | 39.03B 3,527.51% | -2.27B 105.81% | -4.56B 101.37% | 263.81B 5,881.50% | -43.13B 116.35% | -5.34B 87.62% | -115.63B 2,065.39% | 659M 100.57% | |
net cash used provided by financing activities | -27.16B - | -15.72B 42.11% | -42.60B 170.94% | 9.88B 123.19% | -29.61B 399.67% | -28.64B 3.26% | 231.08B 906.71% | -57.22B 124.76% | -21.43B 62.55% | -146.82B 585.23% | 77.85B 153.03% | |
effect of forex changes on cash | 7.95B - | 10.70B 34.63% | -8.22B 176.85% | -1.75B 78.75% | -5.12B 192.62% | 4.50B 188.05% | -113M 102.51% | 4.73B 4,284.96% | 17.75B 275.36% | 24.09B 35.71% | 15.44B 35.91% | |
net change in cash | 2.48B - | 48.88B 1,866.80% | 12.78B 73.85% | -29.97B 334.50% | 42.17B 240.70% | -10.48B 124.85% | -35.59B 239.61% | 91.99B 358.49% | 9.29B 89.91% | -59.51B 740.81% | -114.43B 92.30% | |
cash at beginning of period | 71.43B - | 73.92B 3.48% | 122.79B 66.12% | 135.57B 10.41% | 105.60B 22.11% | 147.78B 39.93% | 137.30B 7.09% | 101.71B 25.92% | 193.70B 90.45% | 202.98B 4.79% | 143.48B 29.32% | |
cash at end of period | 73.92B - | 122.79B 66.12% | 135.57B 10.41% | 105.60B 22.11% | 147.78B 39.93% | 137.30B 7.09% | 101.71B 25.92% | 193.70B 90.45% | 202.98B 4.79% | 143.48B 29.32% | 29.05B 79.76% | |
operating cash flow | 49.94B - | 30.25B 39.43% | 49.41B 63.35% | 21.62B 56.24% | 93.42B 332.02% | 48.71B 47.86% | 46.13B 5.30% | 135.60B 193.97% | 31.24B 76.96% | 11.94B 61.79% | -241.89B 2,126.41% | |
capital expenditure | -21.56B - | -12.37B 42.63% | -9.74B 21.24% | -13.46B 38.18% | -12.35B 8.21% | -12.91B 4.53% | -13.35B 3.38% | -10.81B 19.06% | -13.49B 24.88% | -12.74B 5.57% | -15.73B 23.45% | |
free cash flow | 28.39B - | 17.89B 37.00% | 39.67B 121.83% | 8.16B 79.42% | 81.07B 892.85% | 35.80B 55.84% | 32.78B 8.44% | 124.80B 280.74% | 17.75B 85.78% | -805M 104.54% | -257.62B 31,902.86% |
All numbers in (except ratios and percentages)